ZA831019B - Pharmaceutical compositions containing 3-hydroxybutanoic acid or a salt derived from this acid,and compounds derived from 3-hydroxybutanoic acid which can be used as medicaments - Google Patents

Pharmaceutical compositions containing 3-hydroxybutanoic acid or a salt derived from this acid,and compounds derived from 3-hydroxybutanoic acid which can be used as medicaments

Info

Publication number
ZA831019B
ZA831019B ZA831019A ZA831019A ZA831019B ZA 831019 B ZA831019 B ZA 831019B ZA 831019 A ZA831019 A ZA 831019A ZA 831019 A ZA831019 A ZA 831019A ZA 831019 B ZA831019 B ZA 831019B
Authority
ZA
South Africa
Prior art keywords
acid
hydroxybutanoic acid
derived
pharmaceutical compositions
compositions containing
Prior art date
Application number
ZA831019A
Other languages
English (en)
Inventor
Jacques Lammerant
Jaroslaw Kolanowski
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay filed Critical Solvay
Publication of ZA831019B publication Critical patent/ZA831019B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA831019A 1982-02-23 1983-02-15 Pharmaceutical compositions containing 3-hydroxybutanoic acid or a salt derived from this acid,and compounds derived from 3-hydroxybutanoic acid which can be used as medicaments ZA831019B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8203100A FR2521857B1 (fr) 1982-02-23 1982-02-23 Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee

Publications (1)

Publication Number Publication Date
ZA831019B true ZA831019B (en) 1983-11-30

Family

ID=9271331

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA831019A ZA831019B (en) 1982-02-23 1983-02-15 Pharmaceutical compositions containing 3-hydroxybutanoic acid or a salt derived from this acid,and compounds derived from 3-hydroxybutanoic acid which can be used as medicaments

Country Status (21)

Country Link
US (2) US4579955A (ko)
EP (1) EP0087192B1 (ko)
JP (1) JPS58201746A (ko)
KR (1) KR910000143B1 (ko)
AT (1) ATE24478T1 (ko)
AU (2) AU560757B2 (ko)
CA (1) CA1203242A (ko)
DE (1) DE3368601D1 (ko)
DK (1) DK163235C (ko)
ES (2) ES8500240A1 (ko)
FI (1) FI79523C (ko)
FR (1) FR2521857B1 (ko)
GR (1) GR77934B (ko)
IE (1) IE54561B1 (ko)
IL (1) IL67965A0 (ko)
MX (1) MX156855A (ko)
NO (1) NO161909C (ko)
NZ (1) NZ203279A (ko)
PH (1) PH21561A (ko)
PT (1) PT76267A (ko)
ZA (1) ZA831019B (ko)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
US6020007A (en) * 1984-06-22 2000-02-01 Btg International Limited Fluid therapy with l-lactate and/or pyruvate anions
USRE38604E1 (en) 1984-06-22 2004-09-28 Btg International Limited Fluid therapy with L-lactate and/or pyruvate anions
US4777288A (en) * 1987-06-11 1988-10-11 Pfizer Inc. Process for preparing a 4,4-diphenylbutanoic acid derivative
BE1001209A3 (fr) * 1987-11-19 1989-08-22 Solvay Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
US5292774A (en) * 1988-07-26 1994-03-08 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Substitution fluid preparation comprising 3-hydroxy-butyric acid (β-hydroxybutric acid) and its salts
DE4113984C2 (de) * 1991-04-29 2002-05-08 Koehler Chemie Dr Franz Salze der 4-Hydroxy-Buttersäure
ES2051222B1 (es) * 1992-03-12 1995-02-16 Sanmiguel Gabriel Serrano Procedimiento de neutralizacion de acido alfa-hidroxietanoico.
JP4598203B2 (ja) 1995-12-01 2010-12-15 ビーティージー・インターナショナル・リミテッド 脳機能改善剤
DK2283834T3 (en) * 1997-03-17 2016-08-15 Btg Int Ltd Therapeutic compositions comprising ketone compounds and precursors thereof
US6323237B1 (en) 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
US6316038B1 (en) 1997-03-17 2001-11-13 Btg International Limited Therapeutic compositions
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
US6613356B1 (en) 2000-10-10 2003-09-02 Victor Vlahakos Weight loss medication and method
GB0420856D0 (en) * 2004-09-20 2004-10-20 Ketocytonyx Inc Cns modulators
WO2006020137A2 (en) * 2004-07-16 2006-02-23 Ketocytonyx Inc. Oligomeric compounds
WO2006020179A2 (en) * 2004-07-20 2006-02-23 Ketocytonyx Inc. Oligomeric ketone compounds
WO2006012490A2 (en) * 2004-07-23 2006-02-02 Ketocytonyx Inc. Ketogenic saccharides
EP1793813A4 (en) * 2004-09-21 2011-05-18 Btg Int Ltd TREATMENT OF HYPERACTIVITY DISORDER WITH DEFICIT ATTENTION (ADHD)
WO2006034361A2 (en) * 2004-09-21 2006-03-30 Ketocytonyx Inc. Dopaminergic mimetics
EP2078522B1 (en) 2006-10-30 2012-09-05 Ophtecs Corporation Composition for treating allergy
WO2014071389A1 (en) 2012-11-05 2014-05-08 Veech Richard L Ketone bodies to protect tissues from damage by ionizing radiation
EP3385250B1 (en) 2015-11-19 2021-10-20 Kyowa Hakko Bio Co., Ltd. Crystals of monovalent cation salt of 3-hydroxyisovaleric acid, and method for producing said crystals
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
JP6710098B2 (ja) * 2016-05-10 2020-06-17 大阪瓦斯株式会社 栄養剤組成物及び栄養補助食品
SG11201811493UA (en) * 2016-06-24 2019-01-30 Otsuka Pharma Factory Inc Crystal of amino acid salt of 3-hydroxyisovaleric acid and production method thereof
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
CN112341331B (zh) * 2019-08-07 2023-04-07 辽宁科硕营养科技股份有限公司 一种3-羟基丁酸盐及其制备方法与应用
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2101097A (en) * 1934-07-26 1937-12-07 Wm S Merrell Co Products for rendering the urine bacteriostatic
US2799684A (en) * 1954-06-18 1957-07-16 Food Chemical And Res Lab Inc Crystalline compounds of tryptophane and methods of manufacturing them
NL279760A (ko) * 1961-06-17
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
DE2733202A1 (de) * 1976-08-04 1978-02-09 Agroferm Ag Verfahren zur herstellung der d(-)-3-hydroxybuttersaeure
US4412943A (en) * 1981-02-23 1983-11-01 Kao Soap Co., Ltd. Liquid detergent composition
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee

Also Published As

Publication number Publication date
NO161909C (no) 1989-10-11
NZ203279A (en) 1985-04-30
ES519991A0 (es) 1984-10-01
IL67965A0 (en) 1983-06-15
FR2521857B1 (fr) 1985-10-31
AU602329B2 (en) 1990-10-11
JPS58201746A (ja) 1983-11-24
DK81583A (da) 1983-08-24
FI79523C (fi) 1990-01-10
AU560757B2 (en) 1987-04-16
ES8500240A1 (es) 1984-10-01
ES532880A0 (es) 1985-07-01
ES8506283A1 (es) 1985-07-01
ATE24478T1 (de) 1987-01-15
DE3368601D1 (en) 1987-02-05
US4579955A (en) 1986-04-01
NO830618L (no) 1983-08-24
DK163235C (da) 1992-06-29
DK163235B (da) 1992-02-10
PH21561A (en) 1987-12-11
FI79523B (fi) 1989-09-29
FI830603A0 (fi) 1983-02-23
PT76267A (fr) 1983-03-01
AU1162483A (en) 1983-09-01
KR910000143B1 (ko) 1991-01-21
CA1203242A (fr) 1986-04-15
KR840003414A (ko) 1984-09-08
US4771074A (en) 1988-09-13
NO161909B (no) 1989-07-03
FR2521857A1 (fr) 1983-08-26
AU6916187A (en) 1987-05-21
EP0087192A1 (fr) 1983-08-31
EP0087192B1 (fr) 1986-12-30
DK81583D0 (da) 1983-02-23
FI830603L (fi) 1983-08-24
MX156855A (es) 1988-10-07
IE830366L (en) 1983-08-23
GR77934B (ko) 1984-09-25
IE54561B1 (en) 1989-11-22

Similar Documents

Publication Publication Date Title
ZA831019B (en) Pharmaceutical compositions containing 3-hydroxybutanoic acid or a salt derived from this acid,and compounds derived from 3-hydroxybutanoic acid which can be used as medicaments
NZ225758A (en) Substituted amine derivatives; pharmaceutical compositions and processes for preparation
CY1105381T1 (el) Αλατα βορονικου οξεως
DE3469534D1 (en) Modified proteinase inhibitors, process for their preparation and pharmaceutical compositions containing them
IL127352A (en) Pyridyl alkene- and pyridyl alkine-acid amides and pharmaceutical compositions containing them
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
IL104716A (en) 7-1-oxo-2- (substituted mercapto)-3- phenylpropyl) amino| octahydro-6-pyrido £2, 1-a| benzazepine- 4-carboxylic acid derivatives and analogs, their preparation and pharmaceutical compositions containing them for inhibiting enkephalinase and ace
ES8704482A1 (es) Procedimiento para la preparacion de silibinina extenta de isosilibina
NZ234501A (en) Hemoregulatory peptides and pharmaceutical compositions containing them
NZ217007A (en) Peptide derivative which inhibits proteases, preparation and pharmaceutical composition
ES8403487A1 (es) "procedimiento para la preparacion de n-(2-metoxietil)-noroximorfona".
GR3004764T3 (ko)
DE3466213D1 (en) Arphamenine and its related compounds, a process for their preparation and their use as medicaments
ZA941196B (en) Angiopeptin cyclopeptide compounds process for the preparation thereof and pharmaceutical compositions containing them
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it
JO1711B1 (en) Therapeutic agents
IT1265045B1 (it) Composizione farmaceutica atta a inibire la sintesi della lipoproteina (a)